HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel heterozygous missense mutation (His127Arg) in a family with inherited cross-reacting material positive factor XI deficiency.

Abstract
Factor XI (FXI) deficiency is an autosomal inherited coagulation disorder, characterized by an inconsistent bleeding tendency, mainly associated with injury or surgery. Although most of the F11 gene mutations cause a true quantitative deficiency of FXI (cross-reacting material-negative, CRM-), very few variants characterized by a qualitative abnormality resulting in a discrepant FXI activity/FXI antigen ratio (CRM positive, CRM+) have been reported. We describe here a novel CRM+ mutation (His127Arg) identified in an asymptomatic woman from Indonesia and in her two sons.
AuthorsGiancarlo Castaman, Sofia H Giacomelli, Annarita Tagliaferri, Francesco Rodeghiero
JournalBlood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis (Blood Coagul Fibrinolysis) Vol. 24 Issue 6 Pg. 670-2 (Sep 2013) ISSN: 1473-5733 [Electronic] England
PMID23571684 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Factor XI
Topics
  • Factor XI (genetics)
  • Factor XI Deficiency (blood, genetics)
  • Female
  • Heterozygote
  • Humans
  • Middle Aged
  • Models, Molecular
  • Mutation, Missense

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: